SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005477-04-001771
Filing Date
2004-05-04
Accepted
2004-05-04 16:05:39
Documents
1
Period of Report
2004-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 edgar123.html 5  
1 FORM 5 edgar123.xml 5 4197
  Complete submission text file 0001005477-04-001771.txt   6148
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O REPLIGEN CORP 41 SEYON ST. BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address C/O REPLIGEN CORP 41 SEYON ST. BUILDING 1, SUITE 100 WALTHAM MA 02453 7812500111
RUSCHE JAMES R (Reporting) CIK: 0001241031 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-14656 | Film No.: 04777879